tolbutamide has been researched along with Ischemic Attack, Transient in 2 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trautwein, H | 1 |
| Julitz, R | 1 |
| Finestone, AJ | 1 |
| Bagan, S | 1 |
2 other studies available for tolbutamide and Ischemic Attack, Transient
| Article | Year |
|---|---|
[Diabetic metabolism and arteriosclerosis].
Topics: Adult; Aged; Arteries; Arteriosclerosis; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopa | 1973 |
Mistaken drug identity mimicking cerebral vascular insufficiency.
Topics: Aged; Diabetes Mellitus; Diagnosis, Differential; Drug Labeling; Female; Humans; Ischemic Attack, Tr | 1970 |